Beckman Coulter's Q4 Revenues Rise 22 Percent Aided by Olympus Acquisition

The Olympus Diagnostics business that Beckman Coulter acquired last summer provided a $120 million contribution for the fourth quarter. The firm beat analysts' consensus estimate, despite a drag from cash instrument sales during the quarter.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories